Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Draft NICE guidance does not recommend mifamurtide

    • 10 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Draft NICE guidance does not recommend mifamurtide. Pharmacoecon. Outcomes News 614, 9 (2010). https://doi.org/10.2165/00151234-201006140-00020

    Download citation


    • Public Health
    • Clinical Practice
    • Health Outcome
    • Treatment Effect
    • Osteosarcoma